Novonesis A/S

NSIS B

DK0060336014

Specialty Chemicals

Real-time Estimate Cboe Europe Other stock markets 05:26:55 2024-04-25 am EDT			5-day change	1st Jan Change
387.6 ^DKK	-0.09%		+1.28%	+4.45%

Apr. 08	Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	CI
Mar. 26	China to speed up 'new productive forces', vice president says	RE

Novozymes A/S : completes acquisition of Microbiome Labs

January 08, 2021 at 02:50 am EST

Please read the full release in PDF

Attachment

2021_Acquisition_of_Microbiome_Labs_Completed

Latest news about Novonesis A/S

Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	Apr. 08	CI
China to speed up 'new productive forces', vice president says	Mar. 26	RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	Mar. 21	DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024	Mar. 21
Novonensis expects 2024 adjusted EBITDA margin of 35%	Mar. 21	RE
Novonesis Provides Earnings Guidance for the Year 2024	Mar. 21	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	Mar. 18	MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	Mar. 18	CI
FMC Partners With Novonesis in Canada for Biosolution Products	Mar. 12	MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	Mar. 07	CI
Novozymes A/S Announces Board Appointments	Mar. 04	CI
Transcript : Novozymes A/S - Shareholder/Analyst Call	Mar. 04
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030	Feb. 12	RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments	Feb. 08
Novozymes, Chr. Hansen Complete Merger Settlement	Feb. 02	MT
Transcript : Novozymes A/S, 2023 Earnings Call, Feb 01, 2024	Feb. 01
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares	Jan. 29	MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S.	Jan. 28	CI
Novozymes, Chr. Hansen’s Proposed Merger Secures All Regulatory Approvals	Jan. 26	MT
Novozymes, Chr. Hansen Merger Wins Korean Regulatory Nod	Dec. 20	MT
Global markets live: BAE Systems, Amazon, Take-Two, Shell, Pfizer...	Dec. 13
Celadon Pharma raises GBP2.0 million via placing	Dec. 12	AN
Novozymes-Chr. Hansen Merger Gets EU Nod After Proposed Asset Sale	Dec. 12	MT
Kerry Group Buys Novozymes, Chr. Hansen Assets for EUR150 Million	Dec. 12	DJ

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).

Sector

Specialty Chemicals

Calendar

2024-04-30 - Annual General Meeting

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments

February 08, 2024 at 09:18 am EST

More Strategies

Ratings for Novonesis A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

387.9 DKK

Average target price

430.9 DKK

Spread / Average Target

+11.08%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Industrial Biotechnology Chemicals

	1st Jan change	Capi.
NOVONESIS A/S	+4.45%	25.83B
CATHAY BIOTECH INC.	-26.59%	3.25B
BORREGAARD ASA	+10.27%	1.73B
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	-27.06%	380M
BIO-ON S.P.A.	-81.65%	216M
CHEMCON SPECIALITY CHEMICALS LIMITED	-9.88%	116M
I-TECH AB	-15.58%	51.4M

Industrial Biotechnology Chemicals

Novonesis A/S

Equities

NSIS B

DK0060336014

Specialty Chemicals

Novozymes A/S : completes acquisition of Microbiome Labs

Latest news about Novonesis A/S

Chart Novonesis A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Novonesis A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Industrial Biotechnology Chemicals